What are the latest clinical recommendations for managing insulin-resistant PCOS weight gain when low-carb diets and Metformin have plateaued my progress?
Download run
Fan-out diagram
The searches the AI actually ran for this prompt.
SEED QUERY
What are the latest clinical recommendations for managing insulin-resistant PCOS weight gain when low-carb diets and Metformin have plateaued my progress?
3 real searches · 1 real-search pass
2023 international evidence-based guideline PCOS weight management GLP-1 receptor agonists anti-obesity medications recommendations metforminGoogle ↗
OBSERVED
2025 2026 clinical recommendations PCOS obesity GLP-1 semaglutide tirzepatide guideline updateGoogle ↗
OBSERVED
PCOS guideline anti-obesity pharmacological agents GLP-1 receptor agonists contraception pregnancy lifestyle metformin plateau evidenceGoogle ↗
OBSERVED
Badge and edge weight = share of passes that produced the query. Hover a query for its intent and routing format.
Query classes
Google's semantic query class for every sub-query: what kind of answer each search is after, simulated vs real.
Classifying 3 queries…
Searches and sources
ChatGPT3 real searches · gpt-6
2023 international evidence-based guideline PCOS weight management GLP-1 receptor agonists anti-obesity medications recommendations metformin Google ↗
2025 2026 clinical recommendations PCOS obesity GLP-1 semaglutide tirzepatide guideline update Google ↗
PCOS guideline anti-obesity pharmacological agents GLP-1 receptor agonists contraception pregnancy lifestyle metformin plateau evidence Google ↗
- Recommendations from the 2023 International Evidence-based Guideline for the Assessment and Management of Polyendocrine Metabolic Ovarian Syndrome (2023) | American Society for Reproductive Medicine · prod.asrm.org
- Pharmacologic Treatments With Lifestyle Modifications in Nonpregnant Adults With Overweight or Obesity in Outpatient Settings: A Living Clinical Guideline From the American College of Physicians (April 2026). · pubmed.ncbi.nlm.nih.gov
- Recommendations from the 2023 International Evidence-based Guideline for the Assessment and Management of Polycystic Ovary Syndrome · pmc.ncbi.nlm.nih.gov
- Summary of the 2023 international evidence‐based guideline for the assessment and management of polycystic ovary syndrome: an Australian perspective - Teede - 2024 - Medical Journal of Australia · onlinelibrary.wiley.com
Queries
3 queries · click a column to sort
| Query / type | Search | Intent | Query class | Routing format | Cluster | Freq ↓ | Weight |
|---|---|---|---|---|---|---|---|
2023 international evidence-based guideline PCOS weight management GLP-1 receptor agonists anti-obesity medications recommendations metformin OBSERVED | Google ↗ AI Mode ↗ | — | — | — | — | 1x of 1 | |
2025 2026 clinical recommendations PCOS obesity GLP-1 semaglutide tirzepatide guideline update OBSERVED | Google ↗ AI Mode ↗ | — | — | — | — | 1x of 1 | |
PCOS guideline anti-obesity pharmacological agents GLP-1 receptor agonists contraception pregnancy lifestyle metformin plateau evidence OBSERVED | Google ↗ AI Mode ↗ | — | — | — | — | 1x of 1 |